Topical formulation engendered alteration in p53 and cyclobutane pyrimidine dimer expression in chronic photodamaged
James M Spencer1, Michael B Morgan, Kara M Trapp
1Department of Dermatology, Mount Sinai School of Medicine, New York, NY, USA.
Abstract:
While the clinical attributes of photoaging are well characterized in the literature, the pathogenic mechanisms that underlie these changes are incompletely elucidated. At the molecular level, p53 tumor-suppressor gene product mediated excision repair of ultraviolet (UV)-induced DNA damage is a critical effector in xeroderma pigmentosum (XP) and potentially in conventional photoaging. We examined p53 activity and measured UV-induced DNA damage via cyclobutane pyrimidine dimers (CPDs) quantitatively in 20 volunteers before and after an 8-week, open-label prospective topical application of a proprietary DNA recovery serum (Celfix). There was a statistically significant decrease in immunohistochemically determined p53 and CPD levels. While these data are preliminary, the findings lend support to the theoretical possibility of a topical agent reversing the effects of photodamage at the molecular level and, potentially, an ameliorative outcome clinically.
Insights
This study investigated a DNA recovery serum
Area of Science:
- Dermatology
- Molecular Biology
- Genetics
Background:
- Photoaging's clinical signs are known, but its molecular mechanisms remain unclear.
- Ultraviolet (UV) radiation causes DNA damage, and the p53 protein plays a role in DNA repair.
- This repair mechanism is crucial in xeroderma pigmentosum (XP) and may be involved in typical photoaging.
Purpose of the Study:
- To investigate the effects of a topical DNA recovery serum on molecular markers of photoaging.
- To quantitatively measure changes in p53 activity and UV-induced DNA damage (cyclobutane pyrimidine dimers - CPDs) after serum application.
Main Methods:
- An 8-week, open-label study involving 20 volunteers.
- Topical application of a proprietary DNA recovery serum.
- Quantitative measurement of p53 levels and CPDs using immunohistochemistry before and after treatment.
Main Results:
- A statistically significant reduction in both p53 levels and CPDs was observed.
- Immunohistochemical analysis confirmed these molecular changes.
Conclusions:
- Preliminary findings suggest a topical DNA recovery serum may reverse molecular photodamage.
- The results support the potential for clinical improvement in photoaging effects.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Abnormal Proliferation
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...

